Omega-3 Fatty Acids (DHA/EPA) 用于 Mild Cognitive Impairment (MCI)
BResearch suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'braincited.com';
const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dmild\u002Dcognitive\u002Dimpairment';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
结论
Research suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.
Key Study Findings
Systematic Review
n=3582
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Dose: None
vs: Placebo or control
Outcome: Cognitive function in AD and MCI patients
效果: None
None
研究人群: AD and MCI patients aged 50-90 (31 clinical trials)
Randomized Controlled Trial
n=73
12 weeks
Single-blind
Comparing the Efficacy of Combined Intralesional Triamcinolone Acetonide With Topical Calcipotriol Versus Intralesional Triamcinolone Acetonide …
Dose: IL triamcinolone every 4 weeks + calcipotriol twice daily
vs: IL triamcinolone acetonide alone
Outcome: Hair density (regrowth scale)
效果: None
0.018 (scalp subgroup at wk12)
研究人群: Patients with scalp and beard alopecia areata (179 patches)
Review
Effects of Dietary Interventions on Cognitive Outcomes.
Dose: None
vs: None
Outcome: Cognitive outcomes (memory, executive function)
效果: None
None
研究人群: Aging adults with cognitive impairment (review)
Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None
vs: None
Outcome: None
效果: None
None
研究人群: None
Other
Milk Fat Globules: 2024 Updates.
Dose: None
vs: None
Outcome: Inflammatory markers
效果: None
None
研究人群: None
Systematic Review
The Role of Omega-3 Fatty Acid Supplementation in Slowing Cognitive Decline Among Elderly Patients With …
Dose: None
vs: None
Outcome: Cognitive function
效果: None
None
研究人群: Alzheimer's disease patients
Key Statistics
18
研究数量
3200
受试者
↑
Positive
B
等级
Referenced Papers
European journal of …
2025
8 次引用
Nutrients
2025
6 次引用
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Systematic Review
International journal of …
2025
2 次引用
Journal of cutaneous …
2025
European journal of …
2024
16 次引用
Lasers in medical …
2024
10 次引用
Healthcare (Basel, Switzerland)
2024
9 次引用
Newborn (Clarksville, Md.)
2024
9 次引用
Cureus
2024
8 次引用
Journal of cosmetic …
2024
1 次引用
American family physician
2024
Current opinion in …
2023
58 次引用
Nutrition reviews
2023
18 次引用
Archives of dermatological …
2023
3 次引用
Vitamin Supplementation and Dementia: A Systematic Review.
Systematic Review
Nutrients
2022
76 次引用
Brain, behavior, and …
2022
64 次引用
European journal of …
2022
63 次引用
The American journal …
2022
18 次引用
Journal of Ayub …
2022
4 次引用
The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.
Review
Journal of clinical …
2021
38 次引用
Antioxidants (Basel, Switzerland)
2021
33 次引用
Diet enriched in omega-3 fatty acids alleviates olfactory system deficits in APOE4 transgenic mice.
Other
The European journal …
2021
4 次引用
The Senior care …
2021
2 次引用
Nutrients
2020
72 次引用
Journal of cutaneous …
2020
21 次引用
Psychiatrike = Psychiatriki
2020
15 次引用
Journal of Alzheimer's …
2020
14 次引用
FASEB journal : …
2020
8 次引用
Omega-3 fatty acids and cognitive decline: a systematic review.
Systematic Review
Nutricion hospitalaria
2019
40 次引用
Alzheimer's research & …
2019
29 次引用
The journal of …
2018
24 次引用
Journal of Alzheimer's …
2018
12 次引用
FASEB journal : …
2017
41 次引用
Actas espanolas de …
2017
22 次引用
FASEB journal : …
2017
21 次引用
Current Alzheimer research
2017
7 次引用
Journal of Alzheimer's …
2016
128 次引用
NeuroImage
2016
118 次引用
FP essentials
2016
11 次引用
Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis.
Meta-Analysis
Climacteric : the …
2015
92 次引用
Journal of Alzheimer's …
2015
8 次引用
European journal of …
2014
204 次引用
Nutrition (Burbank, Los …
2014
74 次引用
Acta clinica Belgica
2014
44 次引用
Nutricion hospitalaria
2014
17 次引用
Advances in nutrition …
2013
155 次引用
Journal of Alzheimer's …
2012
257 次引用
Journal of Alzheimer's …
2012
137 次引用
Alzheimer disease and …
2011
52 次引用
Molecular neurobiology
2010
145 次引用
Journal of Alzheimer's …
2010
110 次引用
Journal of Alzheimer's …
2010
55 次引用
Women's health (London, …
2010
48 次引用
JAMA
2009
304 次引用
Progress in neuro-psychopharmacology …
2008
388 次引用
Alternative medicine review …
2008
Alternative medicine review …
2007
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 1,000-2,000 mg combined DHA/EPA per day
- cognitivesupport:
- 1,000-1,700 mg/day (optimal dose-response curve)
上限： 3,000 mg/day combined DHA/EPA (FDA GRAS)
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Mixed | 3582 |
| IL triamcinolone every 4 weeks + calcipotriol twice daily | 12 weeks | Positive | 73 |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| Vitamin D3 vs triamcinolone acetonide | 12 weeks | Positive | 40 |
| None | -- | Positive | -- |
最佳服用时间： With meals containing fat for better absorption
Safety & Side Effects
已报告的副作用
- ⚠ Fishy aftertaste or burping
- ⚠ Mild gastrointestinal discomfort
- ⚠ Potential increased bleeding time at very high doses
- ⚠ May lower blood pressure slightly
已知相互作用
- ● Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
- ● Blood pressure medications (additive hypotensive effect)
- ● Orlistat (may reduce omega-3 absorption)
可耐受最高摄入量： 3,000 mg/day combined DHA/EPA (FDA GRAS)
在开始服用任何补充剂之前，请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Omega-3 Fatty Acids (DHA/EPA) help with Mild Cognitive Impairment (MCI)?
Based on 18 studies with 3,200 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (DHA/EPA) may support Mild Cognitive Impairment (MCI) management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Mild Cognitive Impairment (MCI)?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Mild Cognitive Impairment (MCI)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 18 peer-reviewed studies with 3,200 total participants. The overall direction of effect is positive.
Related Evidence
其他成分用于 Mild Cognitive Impairment (MCI)
Omega-3 Fatty Acids (DHA/EPA) 用于其他健康状况
FDA 免责声明: 这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。